Aurinia Pharmaceuticals (AUPH) USPTO patents

Utility

Protocol for Treatment of Lupus Nephritis

21 Jul 22

By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.

Neil SOLOMONS, Robert B. HUIZINGA

Filed: 4 Apr 22

Utility

Ophthalmic Compositions

4 Nov 21

The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.

Ashim K. MITRA, Poonam R. VELAGALETI, Subramanian NATESAN

Filed: 12 Apr 21

Utility

Ophthalmic compositions

13 Apr 21

The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.

Ashim K. Mitra, Poonam R. Velagaleti, Subramanian Natesan

Filed: 8 Feb 19

Reissue

Cyclosporine analogue mixtures and their use as immunomodulating agents

28 Sep 20

The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A.

Selvaraj A. Naicker, Randall W Yatscoff, Robert T Foster

Filed: 29 Jun 14

Utility

Ophthalmic Compositions

8 Jan 20

The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.

Ashim K. Mitra, Poonam R. Velagaleti, Subramanian Natesan

Filed: 7 Feb 19

Utility

Cyclosporine analogue mixtures and their use as immunomodulating agents

11 Nov 19

The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A.

Selvaraj A. Naicker, Randall W Yatscoff, Robert T Foster

Filed: 13 Aug 17